V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210034468 | 210008244 | 1.73 | 85 | Curative (C) | 2013-11-19 | 2014-06-02 | UKALL 14 TRIAL | Y | null | 210015019 | UKALL2014 |
| 210034469 | 210008245 | null | 73.3 | Curative (C) | 2018-01-31 | 2018-07-16 | UKALL14- Intens/CNS Proph | Y | N | 210015020 | UKALL2014 |
| 210034470 | 210008254 | 1.71 | 79 | Disease modification (D) | 2012-09-09 | 2013-10-04 | UKALL14- Ph 2 Induction | N | N | 210015041 | UKALL2014 |
| 210034471 | 210019303 | 1.83 | 90.8 | Curative (C) | 2016-11-23 | 2017-03-08 | UKALL14- Intens/CNS Proph | null | N | 210015062 | UKALL2014 |
| 210034472 | 210008264 | 1.74 | 73.9 | Curative (C) | 2014-05-04 | 2014-05-04 | UKALL14- Maintenance + Imatinib | null | N | 210015067 | UKALL2014 |
| 210034473 | 210008267 | 1.58 | 55.3 | Curative (C) | 2014-03-15 | 2014-03-27 | UKALL14- Intens/CNS Proph | 01 | N | 210015070 | UKALL2014 |
| 210034474 | 210008275 | 1.76 | 75.3 | Curative (C) | 2014-08-12 | 2014-08-12 | UKALL14- Ph 1 Induction | Y | N | 210015090 | UKALL2014 |
| 210034475 | 210008276 | 1.67 | null | null | 2014-03-17 | 2014-03-17 | UKALL14- Ph 2 Induction + Imatinib | N | N | 210015104 | UKALL2014 |
| 210034476 | 210019309 | 1.89 | 62.9 | Curative (C) | null | 2013-07-22 | UKALL14- Ph 2 Induction | N | Y | 210015114 | UKALL2014 |
| 210034477 | 210008287 | null | 71 | Curative (C) | 2013-11-01 | 2014-02-06 | UKALL14- Ph 2 Induction | Y | N | 210015125 | UKALL2014 |
| 210034478 | 210008288 | 1.68 | 71.8 | Curative (C) | 2015-03-24 | 2015-07-07 | UKALL14- Ph 2 Induction | N | null | 210015133 | UKALL2014 |
| 210034479 | 210008294 | 1.62 | 60.9 | Disease modification (D) | 2014-06-05 | 2014-07-25 | UKALL14- Ph 2 Induction | N | Y | 210015141 | UKALL2014 |
| 210034480 | 210008299 | 1.82 | 94.499 | Palliative (P) | 2019-01-05 | 2019-01-05 | UKALL14- Ph 2 Induction | Y | N | 210015173 | UKALL2014 |
| 210034481 | 210019318 | 1.58 | 91.8 | Curative (C) | 2015-05-07 | 2015-05-07 | UKALL14- Ph 2 Induction + Imatinib | 02 | N | 210015192 | UKALL2014 |
| 210034482 | 210008312 | 1.62 | 85 | Curative (C) | 2015-08-03 | 2015-10-06 | UKALL14- Ph 2 Induction | 01 | N | 210015202 | UKALL2014 |
| 210034483 | 210008316 | 1.7 | 74.4 | Curative (C) | 2015-12-19 | 2015-12-24 | UKALL14- Ph 2 Induction | null | N | 210015206 | UKALL2014 |
| 210034484 | 210008323 | null | 80.3 | Palliative (P) | 2016-04-04 | 2016-05-21 | UKALL14- Ph 2 Induction | null | N | 210015216 | UKALL2014 |
| 210034485 | 210008330 | null | 57.7 | Curative (C) | 2014-11-19 | 2014-11-19 | UKALL14- Maintenance | Y | 0 | 210015220 | UKALL2014 |
| 210034486 | 210008336 | 1.51 | 91.8 | Curative (C) | 2015-04-18 | 2015-04-18 | UKALL14- Ph 2 Induction | Y | N | 210015224 | UKALL2014 |
| 210034488 | 210008354 | 0 | 72 | Curative (C) | 2017-08-09 | 2018-05-12 | UKALL14- Intens/CNS Proph | N | N | 210015258 | UKALL2014 |
| 210034489 | 210008359 | null | 65 | Curative (C) | 2015-01-31 | 2015-10-08 | UKALL14- Intens/CNS Proph | Y | null | 210015268 | UKALL2014 |
| 210034490 | 210008366 | 1.89 | 81.1 | Curative (C) | null | 2017-12-25 | UKALL14- Intens/CNS Proph | Y | null | 210015285 | UKALL2014 |
| 210034491 | 210008373 | 1.83 | 60.5 | Curative (C) | 2015-08-13 | 2015-12-25 | UKALL14- Intens/CNS Proph | Y | N | 210015306 | UKALL2014 |
| 210034492 | 210008377 | 1.66 | 67 | Curative (C) | 2016-08-09 | 2016-12-28 | UKALL14- Cons Cycle 1 | 2 | N | 210015308 | UKALL2014 |
| 210034493 | 210008381 | 1.78 | 75 | Curative (C) | 2015-06-18 | 2016-12-17 | UKALL14- Intens/CNS Proph | Y | N | 210015310 | UKALL2014 |
| 210034495 | 210008395 | 1.76 | 86.1 | Curative (C) | 2015-04-12 | 2015-05-24 | UKALL 14 TRIAL | Y | N | 210015323 | UKALL2014 |
| 210034497 | 210008410 | 1.54 | 53 | Curative (C) | 2016-06-09 | 2016-06-21 | UKALL 14 TRIAL | N | N | 210015346 | UKALL2014 |
| 210034498 | 210008423 | 1.89 | 60.5 | Curative (C) | 2014-06-17 | 2015-12-12 | UKALL14- Maintenance | Y | null | 210015414 | UKALL2014 |
| 210034499 | 210008429 | 1.83 | 101.7 | Curative (C) | 2010-11-18 | 2013-09-27 | UKALL14- Intens/CNS Proph | N | null | 210015423 | UKALL2014 |
| 210034500 | 210008433 | 1.68 | 106.499 | Curative (C) | 2015-04-03 | 2015-04-03 | UKALL14- Intens/CNS Proph | Y | null | 210015424 | UKALL2014 |
| 210034501 | 210008447 | 1.73 | 59.4 | Curative (C) | 2016-04-07 | 2016-04-26 | UKALL 14 TRIAL | null | N | 210015447 | UKALL2014 |
| 210034502 | 210008450 | 1.6 | 49.4 | Curative (C) | 2016-04-01 | 2016-09-01 | UKALL 14 TRIAL | null | N | 210015451 | UKALL2014 |
| 210034503 | 210008454 | null | 99.4 | Curative (C) | 2012-06-25 | 2014-01-07 | UKALL14- Maintenance + Imatinib | Y | null | 210015455 | UKALL2014 |
| 210034504 | 210008459 | null | 143.8 | Curative (C) | 2013-04-12 | 2013-08-21 | UKALL14- Intens/CNS Proph | Y | N | 210015471 | UKALL2014 |
| 210034505 | 210008465 | 1.74 | 94.499 | Curative (C) | 2015-11-01 | 2016-05-13 | UKALL14- Maintenance | Y | null | 210015472 | UKALL2014 |
| 210034506 | 210019371 | 1.64 | 60.1 | Curative (C) | 2016-03-12 | 2016-10-22 | UKALL14- Ph 2 Induction | N | N | 210015487 | UKALL2014 |
| 210034507 | 210008481 | 1.45 | 80 | Curative (C) | 2015-09-27 | 2016-01-03 | UKALL14- Intens/CNS Proph | N | null | 210015510 | UKALL2014 |
| 210034508 | 210008493 | 1.82 | 75.3 | Curative (C) | 2019-03-08 | 2019-05-31 | UKALL14- FMC (2 day) Conditioning | Y | N | 210015534 | UKALL2014 |
| 210034509 | 210008496 | 1.57 | 67.8 | Curative (C) | 2018-04-14 | 2018-04-14 | UKALL14- Cons Cycle 2 | N | null | 210015535 | UKALL2014 |
| 210034510 | 210008505 | 1.64 | 56 | Curative (C) | 2017-03-11 | 2018-03-06 | UKALL14- Cons Cycle 3 | 01 | N | 210015563 | UKALL2014 |
| 210034511 | 210008509 | 1.87 | 95.799 | Curative (C) | 2016-05-12 | 2016-09-14 | UKALL14- Cons Cycle 2 | N | N | 210015569 | UKALL2014 |
| 210034512 | 210008512 | 1.74 | 83 | Curative (C) | 2016-03-05 | 2016-11-09 | UKALL14- Cons Cycle 3 | N | N | 210015575 | UKALL2014 |
| 210034513 | 210008515 | 1.55 | 60.8 | Curative (C) | 2016-07-24 | 2017-05-09 | UKALL14- Ph 2 Induction | 01 | N | 210015606 | UKALL2014 |
| 210034514 | 210008519 | 1.57 | 36 | Curative (C) | 2013-12-06 | 2014-02-02 | UKALL 14 TRIAL | 1 | N | 210015612 | UKALL2014 |
| 210034515 | 210008524 | 1.76 | 74.2 | Curative (C) | 2017-06-04 | 2017-12-15 | UKALL14- Maintenance | N | N | 210015620 | UKALL2014 |
| 210034516 | 210026432 | 1.73 | 91.9 | Curative (C) | 2016-01-04 | 2016-07-16 | UKALL14- Cons Cycle 3 | N | N | 210015630 | UKALL2014 |
| 210034517 | 210008532 | 1.75 | 79.4 | Curative (C) | 2016-04-18 | 2017-04-01 | UKALL14- Maintenance | N | null | 210015631 | UKALL2014 |
| 210034518 | 210008539 | 1.65 | 63.1 | Curative (C) | 2015-12-18 | 2016-10-06 | UKALL14- Ph 2 Induction + Imatinib | 01 | N | 210015667 | UKALL2014 |
| 210034519 | 210026436 | 1.75 | 64 | Curative (C) | 2014-01-28 | 2014-06-23 | UKALL14- Maintenance | Y | null | 210015675 | UKALL2014 |
| 210034520 | 210037393 | 1.72 | null | Curative (C) | 2017-09-21 | 2017-09-25 | UKALL14- Maintenance | null | N | 210015677 | UKALL2014 |